ConductScience.org, home

Trial · NCT07888153

Study of Cross-Cutting E-Health Prevention Approaches

NCT07888153, Phase 2, Recruiting, University of New Hampshire

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Study of Cross-Cutting E-Health Prevention Approaches. Trials, record NCT07888153. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888153

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Study of Cross-Cutting E-Health Prevention Approaches
NCT number
NCT07888153
Status
Recruiting
Phases
Phase 2
Enrollment
350 participants, estimated
Lead sponsor
University of New Hampshire
Conditions
Alcohol Misuse Prevention, Sexual Violence Prevention
Interventions
Cross Cutting e-health Prevention Program Individual Interventions
First posted
2026-10-22
Last updated
2026-10-22

Source ClinicalTrials.gov

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySexual Experiences Survey-Short Form VictimizationBaseline, 8 weeks, 16 weeks
Sexual assault victimization was assessed with Revised Sexual Experience Survey. Participants were asked how often they experienced 7 unwanted sexual experiences. Also, the tactic that was used (for example, "using force") was also noted. Response options ranged from 0 (never) to 3 (3 or more times). An overall score for the Revised Sexual Experience Survey, was calculated by Summing each Outcome and Tactic Score with a range from 0 to 135 with higher scores indicating more sexual violence victimization, a worse score than the lower scores. The second method combines several of the outcomes, but keeps tactics separate, resulting in a potential range of 0 to 63 with the higher score being a worse score than the lower score.
PrimarySexual Experiences Survey-Short Form PerpetrationBaseline, 8 weeks, 16 weeks
The Sexual Experiences Survey-Short Form Perpetration is a 7-item, behaviorally specific self-report instrument designed to assess the perpetration of unwanted sexual behaviors. It covers sexual coercion, unwanted contact, attempted rape, and rape, typically asking about acts committed since age 14 or in the past year. The higher score indicates more unwanted sexual experiences and therefore is a worse score than a lower score.
PrimaryAlcohol Use Disorders Identification Test-ConciseBaseline, 8 weeks, 16 weeks
The Alcohol Use Disorders Identification Test is a 10-item screening tool developed by the World Health Organization to assess alcohol consumption, drinking behaviors, and alcohol-related problems. The higher the score indicates more alcohol related problems, therefore a worse score.
PrimaryDrinking Behavior QuestionnaireBaseline, 8 weeks, 16 weeksA ten-item self report measure looking at an individual's drinking habits. The higher the score indicates more problematic drinking habits, therefore a worse score.
SecondaryBystander Attitudes Scale RevisedBaseline, 8 weeks, 16 weeks
12-item measure of attitudes towards bystander behaviors. Higher scores are better scores indicating that the participant is more willing to engage in prosocial bystander intervention before, during, or after sexual assault or violence situations.
SecondaryBarriers to Sexual Assault Bystander Intervention ScaleBaseline, 8 weeks, 16 weeks
The Barriers to Sexual Assault Bystander Intervention Scale is a 16-item, 7-point Likert-scale questionnaire that measures five key psychological barriers hindering bystander intervention in sexual violence. It assesses failure to notice, interpret risk, take responsibility, possess skills, or fear of negative evaluation. Higher scores are worse scores indicating greater perceived barriers to prosocial bystander intervention.
SecondarySocial Self-identification Scale8 weeks, 16 weeks
4-item measure to assess the relevancy of the intervention to the participant's life. The higher score indicates that intervention was more relevant to the participant's life indicating a better score.
SecondaryBystander Efficacy ScaleBaseline, 8 weeks, 16 weeks
The Bystander Efficacy Scale measures the effectiveness of sexual violence prevention programs based on preventing antecedents to sexual violence by increasing prosocial bystander behavior. On this measure, participants are asked to indicate their confidence, on an 11-point scale, in performing each of the listed 14 bystander behaviors. Higher average scores are better scores indicating a person's greater bystander self-efficacy (higher confidence in one's ability to intervene).
SecondaryUpdated Illinois Rape Myth Acceptance Scale,Baseline, 8 weeks, 16 weeks
The Updated Illinois Rape Myth Acceptance Scale, is a 22-item instrument designed to measure contemporary, often subtle, rape-supportive beliefs. It updates the original 45-item scale to reflect modern language and attitudes, aiming to reduce social desirability bias, featuring a 5-point Likert scale (1 = Strongly Agree, 5 = Strongly Disagree). The higher the score is the worse score indicating that the participants holds negative rape myth scores.
SecondaryIntent to Help Friends-Stranger ScaleBaseline, 8 weeks, 16 weeks
Intent to Help Friends-Stranger Scale is a psychometric instrument designed to measure a bystander's intention to intervene in situations involving interpersonal violence (sexual assault, dating violence) depending on their relationship to the victim. The higher the score is the better score indicating participants are more willing to help a friend or stranger in a probably dangerous situation.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers15

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
20522887BACKGROUNDPubMed
21727157BACKGROUNDPubMed
22559087BACKGROUNDPubMed
24850763BACKGROUNDPubMed
25198417BACKGROUNDPubMed
26408290BACKGROUNDPubMed
27593559BACKGROUNDPubMed
29447618BACKGROUNDPubMed
29996689BACKGROUNDPubMed
30183345BACKGROUNDPubMed

1 to 10 of 15

See all 15 papers

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
R15AA031809A pilot study of cross-cutting e-health prevention approaches to address campus sexual assault and alcohol misusePOTTER, SHARYN JUNIVERSITY OF NEW HAMPSHIRENATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM2025

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07888153

GET https://conductscience.org/api/trials/v1/NCT07888153/registered